Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protocadherin gamma-A10 (PCDHGA10) is a member of the protocadherin gamma gene cluster within the cadherin superfamily of calcium-dependent cell adhesion molecules. It is primarily expressed in the brain and thought to play a critical role in establishing and maintaining specific neuronal connections. The gamma cluster contains multiple related genes organized in an immunoglobulin-like array, with each gene encoding a protein potentially involved in neural cell adhesion and signaling. Alterations in protocadherin genes, including PCDHGA10, have been linked to certain neurodevelopmental disorders, but this molecule is not a current therapeutic drug target and no drugs are known to interact with it[1][2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protocadherin gamma-A10 (PCDHGA10).